Macrocure (MCUR) Climbs to Session High

October 10, 2016 10:02 AM EDT

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Macrocure (NASDAQ: MCUR) gained Monday morning, rising 30%. Earlier Leap Therapeutics announced the presentation of top-line data from its clinical trial of DKN-01 combination therapy in patients with cholangiocarcinoma at ESMO.

Previously Leap has signed a merger agreement with Macrocure.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Momentum Movers, Trader Talk

Related Entities

Definitive Agreement

Add Your Comment